EUVIMEDEUVIMED entdecken
Open Access

Follow-up for patients with extremity soft tissue sarcoma: validation of a rational schedule

Maroun Rizkallah, Jasson Arcinue, Ahmed Aoude, Robert Turcotte

Korean Journal of Clinical Oncology · 30.04.2026 · 22 (1) · 1-7

DOI: 10.14216/kjco.25379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Korean Journal of Clinical Oncology, online erschienen am 30.04.2026. Verfasst von Maroun Rizkallah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopedic Surgery, Dr. Georges-L.-Dumont University Hospital Centre, Moncton, NB, Canada. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Patients with soft tissue sarcomas (STS) of the extremity require ongoing follow-up to detect treatment failures. There is a significant variation in follow-up schemes among sarcoma specialists due to a lack of evidence.

Methods

A retrospective single-center review was performed on all patients with a minimum 1-year follow-up after resection of a localized STS, utilizing a prospectively collected database. Kaplan-Meier curves were used to calculate the incidence of local recurrence and metastases on an annual basis over 10 years.

Results

There were 407 patients who met the inclusion criteria. Considering the annual incidence of local recurrence and distant metastasis per STS size and grade, patients with small, low-grade STS should be followed yearly for 10 years. Patients with small, intermediate/high-grade STS and those with large, low-grade STS should be followed every 6 months for the first 2 years and then yearly until 10 years postoperatively. Patients with large, intermediate/high-grade STS should be followed every 3 months for the first 2 years and then every 6 months thereafter until 10 years postoperatively.

Conclusion

Compared to National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology (ESMO) guidelines, our proposed scheme has the potential to reduce hospital visits, mainly for patients with small intermediate and high-grade tumors. This protocol validates the previously published scheme, despite being relatively more conservative.

Schlagwörter

Stichwörter der Autor:innen

ExtremitiesFollow-up studiesRetrospective studiesSarcomaTreatment failures

Autor:innen und Institutionen

  • Division of Orthopedic Surgery, Dr. Georges-L.-Dumont University Hospital Centre, Moncton, NB, Canada.
  • Centre de formation médicale du Nouveau-Brunswick, University of Sherbrooke, Moncton, NB, Canada.
  • Department of Orthopedic Surgery, Jose B. Lingad Memorial Regional Hospital, San Fernando, Philippines.
  • Department of Orthopedic Surgery, McGill University Health Centre, Montreal, QC, Canada.

Zitieren

APA

Rizkallah, M., Arcinue, J., Aoude, A., & Turcotte, R. (2026). Follow-up for patients with extremity soft tissue sarcoma: validation of a rational schedule. Korean Journal of Clinical Oncology, 22(1), 1-7. https://doi.org/10.14216/kjco.25379

Vancouver

Rizkallah M, Arcinue J, Aoude A, Turcotte R. Follow-up for patients with extremity soft tissue sarcoma: validation of a rational schedule. Korean Journal of Clinical Oncology. 2026;22(1):1-7. doi:10.14216/kjco.25379

BibTeX
@article{Rizkallah2026,
  author = {Rizkallah, Maroun and Arcinue, Jasson and Aoude, Ahmed and Turcotte, Robert},
  title = {Follow-up for patients with extremity soft tissue sarcoma: validation of a rational schedule},
  journal = {Korean Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {1},
  pages = {1--7},
  doi = {10.14216/kjco.25379}
}
Kostenlos starten →